ALPINE IMMUNE SCIENCES, INC. Debt Securities, Unrealized Gain (Loss)
ALPINE IMMUNE SCIENCES, INC. reported Debt Securities, Unrealized Gain (Loss) of -$600.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesUnrealizedGainLoss · last filed 2023-03-23
- ALPINE IMMUNE SCIENCES, INC. debt securities, unrealized gain (loss) for the quarter ending 2022-12-31 was -$1.10M.
- ALPINE IMMUNE SCIENCES, INC. debt securities, unrealized gain (loss) for fiscal 2022 was -$600.00K.
- ALPINE IMMUNE SCIENCES, INC. debt securities, unrealized gain (loss) for fiscal 2021 was $0.00.
| Period end | Debt Securities, Unrealized Gain (Loss) 3 month | Debt Securities, Unrealized Gain (Loss) 9 month | Debt Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|
| 2022-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$600.00K 10-K · filed 2023-03-23 | |
| 2022-09-30 | $500.00K 10-Q · filed 2022-11-14 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |